Nephrotic syndrome: genes and variants
Explore variant evidence for Nephrotic syndrome across 10 analyzed proteins (NPHS2, NPHS1, WT1, NOS1AP, NR3C1 and 5 more). Linked ClinVar records include 42 pathogenic or likely pathogenic variants, 78 variants of uncertain significance and 37 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Nephrotic syndrome
NPHS2: Podocin
It organizes nephrin-containing slit-diaphragm complexes in podocytes and helps maintain the glomerular filtration barrier. Biallelic pathogenic variants are a major cause of steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis.
30 ClinVar pathogenic / likely pathogenic and 59 uncertain variants in NPHS2 have source records linked to Nephrotic syndrome. Association strength is not clinical gene validity.
NPHS1: Nephrin
It forms a key structural and signaling component of the slit diaphragm between glomerular podocyte foot processes. Biallelic loss-of-function variants cause congenital nephrotic syndrome of the Finnish type with massive protein loss beginning early in life.
4 ClinVar pathogenic / likely pathogenic and 53 uncertain variants in NPHS1 have source records linked to Nephrotic syndrome. Association strength is not clinical gene validity.
WT1: Wilms tumor protein
It controls transcriptional programs required for kidney and gonadal development and also restrains or promotes cell growth in a context-dependent manner. Germline pathogenic variants cause Wilms-tumor predisposition and Denys-Drash or Frasier syndromes, while somatic alterations occur in some leukemias.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in WT1 have source records linked to Nephrotic syndrome. Association strength is not clinical gene validity.
NOS1AP: Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein
It regulates neuronal nitric-oxide signaling and interacts with proteins that influence cardiac repolarization and synaptic function. Common variants near the locus are reproducibly associated with QT-interval duration, but large-effect monogenic disease from NOS1AP variants is not well established.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in NOS1AP have source records linked to Nephrotic syndrome. Association strength is not clinical gene validity.
NR3C1: Glucocorticoid receptor
It converts glucocorticoid binding into transcriptional programs that regulate metabolism, stress responses, inflammation, and immune activity. Loss-of-function variants can cause glucocorticoid resistance, while excessive or prolonged signaling underlies many adverse effects of corticosteroid therapy.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NR3C1 have source records linked to Nephrotic syndrome. Association strength is not clinical gene validity.
SLC12A1: Solute carrier family 12 member 1
It reabsorbs sodium, potassium, and chloride in the thick ascending limb of the kidney, helping generate the medullary concentration gradient and maintain salt balance. Biallelic loss-of-function variants cause Bartter syndrome type 1 with renal salt wasting.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SLC12A1 have source records linked to Nephrotic syndrome. Association strength is not clinical gene validity.
SLC12A3: Solute carrier family 12 member 3
It reabsorbs sodium and chloride in the distal convoluted tubule and is a major determinant of renal salt and magnesium handling. Biallelic loss-of-function variants cause Gitelman syndrome with hypokalemic metabolic alkalosis, hypomagnesemia, and low urinary calcium.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SLC12A3 have source records linked to Nephrotic syndrome. Association strength is not clinical gene validity.
FAT1: Protocadherin Fat 1
A large cell-surface cadherin involved in cell polarity, cell-cell contact, and directed cell migration. These functions help organize developing and renewing tissues.
4 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in FAT1 have source records linked to Nephrotic syndrome. Association strength is not clinical gene validity.
COL4A4: Collagen alpha-4(IV) chain
It combines with the alpha3 and alpha5 chains to form the mature type IV collagen network of glomerular, cochlear, and ocular basement membranes. Pathogenic variants cause autosomal Alport-spectrum disease and can present with isolated persistent hematuria.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in COL4A4 have source records linked to Nephrotic syndrome. Association strength is not clinical gene validity.
COL4A5: Collagen alpha-5(IV) chain
It is essential for the alpha3-alpha4-alpha5 type IV collagen network that gives glomerular and cochlear basement membranes their mature mechanical properties. Pathogenic variants cause X-linked Alport syndrome, with progressive kidney disease, hearing loss, and characteristic ocular findings.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in COL4A5 have source records linked to Nephrotic syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CLCN5.
ClinVar pathogenic and likely pathogenic variants linked to Nephrotic syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NPHS2 R168C | 168 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 R168H | 168 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 E310K | 310 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 L169P | 169 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 E198A | 198 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 L327F | 327 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 V260E | 260 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 R291W | 291 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 P118L | 118 | Intramembrane | Pathogenic / likely pathogenic (★★) |
| NPHS2 V290M | 290 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 M1L | 1 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 C124R | 124 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 R238S | 238 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 A284V | 284 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 K289E | 289 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS2 R322G | 322 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS1 D105N | 105 | Ig-like C2-type 1 | Pathogenic / likely pathogenic (★★) |
| NPHS2 V180M | 180 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| NPHS1 R976S | 976 | Fibronectin type-III | Pathogenic / likely pathogenic (★★) |
| NPHS2 R138P | 138 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| NPHS2 D160G | 160 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| NPHS2 A308V | 308 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| NPHS1 C417Y | 417 | Ig-like C2-type 4 | Pathogenic / likely pathogenic (★) |
| NPHS2 S120P | 120 | Intramembrane | Pathogenic / likely pathogenic (★) |
| WT1 H405R | 405 | C2H2-type 3 | Pathogenic / likely pathogenic (★) |
| NPHS2 V127I | 127 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| NPHS2 P271L | 271 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| NPHS2 D160V | 160 | Cytoplasmic | Pathogenic / likely pathogenic |
| NPHS2 R138Q | 138 | Cytoplasmic | Pathogenic / likely pathogenic |
| NPHS2 E310V | 310 | Cytoplasmic | Pathogenic / likely pathogenic |
| NPHS1 L643P | 643 | Extracellular | Pathogenic / likely pathogenic |
| NPHS2 M1I | 1 | Cytoplasmic | Pathogenic / likely pathogenic |
| COL4A4 G332V | 332 | Triple-helical region | Pathogenic / likely pathogenic |
| COL4A5 G796E | 796 | Triple-helical region | Pathogenic / likely pathogenic |
| NOS1AP C143Y | 143 | PID | Pathogenic / likely pathogenic |
| FAT1 R3087G | 3087 | Cadherin 28 | Pathogenic / likely pathogenic |
| FAT1 A1003V | 1003 | Cadherin 8 | Pathogenic / likely pathogenic |
| NPHS2 G92C | 92 | Cytoplasmic | Pathogenic / likely pathogenic |
| NPHS2 A248T | 248 | Cytoplasmic | Pathogenic / likely pathogenic |
| NPHS2 N374Y | 374 | Cytoplasmic | Pathogenic / likely pathogenic |
| FAT1 N286S | 286 | Extracellular | Pathogenic / likely pathogenic |
| FAT1 R1506H | 1506 | Cadherin 13 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Nephrotic syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| NPHS2 C124Y | 124 | Cytoplasmic | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; C124R at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.858 |
| NPHS2 R322P | 322 | Cytoplasmic | Conflicting reports (★) | +6: R322G at the same position is pathogenic; REVEL 0.959 |
| NPHS2 P118S | 118 | Intramembrane | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; P118L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.81 |
Which prediction tools work for Nephrotic syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 90 out of 100
- CADD: 90 out of 100
- MetaSVM: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 90 out of 100
- PolyPhen-2: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 87 out of 100
- SIFT: 86 out of 100
- phyloP: 82 out of 100
- SpliceAI: 64 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 31 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Finnish congenital nephrotic syndrome also has ClinVar records linked to NPHS1 variants; they fall mostly in different places as the Nephrotic syndrome variants (70 pathogenic / likely pathogenic).
- X-linked Alport syndrome also has ClinVar records linked to COL4A5 variants; they fall mostly in different places as the Nephrotic syndrome variants (341 pathogenic / likely pathogenic).
- Alport syndrome also has ClinVar records linked to COL4A5 variants; they fall mostly in different places as the Nephrotic syndrome variants (14 pathogenic / likely pathogenic).
- Autosomal recessive Alport syndrome also has ClinVar records linked to COL4A4 variants; they fall mostly in different places as the Nephrotic syndrome variants (99 pathogenic / likely pathogenic).
- Benign familial hematuria also has ClinVar records linked to COL4A4 variants; they fall mostly in different places as the Nephrotic syndrome variants (65 pathogenic / likely pathogenic).
- Alport syndrome also has ClinVar records linked to COL4A4 variants; they fall mostly in different places as the Nephrotic syndrome variants (57 pathogenic / likely pathogenic).
- Autosomal dominant Alport syndrome also has ClinVar records linked to COL4A4 variants; they fall mostly in different places as the Nephrotic syndrome variants (6 pathogenic / likely pathogenic).
- Frasier syndrome also has ClinVar records linked to WT1 variants; they fall mostly in different places as the Nephrotic syndrome variants (6 pathogenic / likely pathogenic).
- Wilms tumor also has ClinVar records linked to WT1 variants; they fall mostly in different places as the Nephrotic syndrome variants (6 pathogenic / likely pathogenic).
- WAGR syndrome also has ClinVar records linked to WT1 variants; they fall mostly in different places as the Nephrotic syndrome variants (5 pathogenic / likely pathogenic).
Diseases related to Nephrotic syndrome
- Kidney disorder, also linked to COL4A5, NPHS1, SLC12A1 and WT1
- Focal segmental glomerulosclerosis, also linked to COL4A4, NPHS1 and NPHS2
- Alport syndrome, also linked to COL4A4 and COL4A5
- Autosomal dominant Alport syndrome, also linked to COL4A4 and COL4A5
- Finnish congenital nephrotic syndrome, also linked to NPHS1 and NPHS2
- Bartter syndrome, also linked to SLC12A1 and SLC12A3
- Multiple myeloma, also linked to FAT1 and NR3C1
- Steroid-resistant nephrotic syndrome, also linked to COL4A5 and NPHS2
- X-linked Alport syndrome, also linked to COL4A5
- Benign familial hematuria, also linked to COL4A4
- Autosomal recessive Alport syndrome, also linked to COL4A4
- Familial hypokalemia-hypomagnesemia, also linked to SLC12A3
Frequently asked questions
Which genes have records linked to Nephrotic syndrome?
This view contains 10 analyzed proteins: NPHS2, NPHS1, WT1, NOS1AP, NR3C1 and 5 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 42 pathogenic or likely pathogenic variants, 78 variants of uncertain significance and 37 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 201 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center